Nicole R. Scholl
Pelotas, RS 96010900, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Recombinant BCG-Ag85A enhances antitumor immunity and controls melanoma progression through multimodal immune activation in mice.
Journal: Archives of microbiology
Published: June 09, 2026
Evaluation of the vaccine formulation with recombinant protein CP01850 and fish oil from Rhamdia quelen: an alternative and innovative adjuvant against Corynebacterium pseudotuberculosis.
Journal: Archives of microbiology
Published: August 01, 2025
Immunotherapeutic and Antitumoral Potential of Fatty Acids from Subantarctic Macroalgae (Sarcopeltis skottsbergii).
Journal: Marine biotechnology (New York, N.Y.)
Published: May 16, 2025
Multi-epitope recombinant chimera and inactivated Escherichia coli expressing chimeric gene of Corynebacterium pseudotuberculosis as vaccines for caseous lymphadenitis.
Journal: Research in veterinary science
Published: March 13, 2025
Recombinant protein CP01850 adjuvanted with Iridea cordata or Sacorpletis skottibergii lipid extracts protected mice against infection by Corynebacterium pseudotuberculosis.
Journal: Biotechnology letters
Published: February 17, 2025
Iridaea cordata lipid extract associated with the rCP01850 protein of C. pseudotuberculosis elicited a Th1 immune response in immunized sheep.
Journal: Vaccine
Published: December 05, 2023
Evaluation of the Association of Recombinant Proteins NanH and PknG from Corynebacterium pseudotuberculosis Using Different Adjuvants as a Recombinant Vaccine in Mice.
Journal: Vaccines
Published: January 25, 2023
In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis.
Journal: Applied microbiology and biotechnology
Published: June 25, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026